Promising Results for Chemo-Free Immunotherapy in Early-Stage Triple-Negative Breast Cancer
Phase 2 trial shows potential for immunotherapy without chemo in early TNBC, especially with high TILs.
B-Cell Lymphomas
2 articles
Long-Term Study Challenges Rituximab Maintenance in Low-Burden Follicular Lymphoma
Extended follow-up of RESORT trial shows rituximab retreatment may be preferable to maintenance therapy.
Acyclovir Prophylaxis Slashes Mucositis Risk in Stem Cell Transplant Patients
Study shows acyclovir prophylaxis significantly reduces oral mucositis in autologous stem cell transplants.